Opening of the center according to the SAN-0867 protocol.

The visit of the opening of the center for the participation of patients in the clinical trial of the drug Broncho-munal® P, capsules, 3.5 mg in the treatment of pediatric patients with acute uncomplicated respiratory tract infections was successfully completed, the study was sponsored by Sandoz.

Our partners

Protagonist
Gilead
Mithra
PRA Health Sciences
Pfizer
Rusmo-AG
Sanofi
Abbvie
Icon
Astra Zeneca
Gedeon Richter
Cromos Pharma
PPD
X7 Research
Synteract
IQVIA
Biorasi | Built for Faster Clinical Trials
PSI
ALK
Galecto
SRG
Clinipas
Astellas
Janssen
JonsonAndJonson
OCT
Celgen
Bristol-Myers Squibb Company
Biogen